Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Expert Opinion on Biological Therapy|August 31, 2007
Gene therapy for mucopolysaccharidosisKatherine P Ponder, Mark E HaskinsHeart and Metabolism : Management of the Coronary Patient|March 4, 2016
Gene therapy for cardiovascular manifestations of lysosomal storage diseasesMeg M Sleeper, Mark E Haskins, Katherine P PonderMolecular Genetics and Metabolism|August 19, 2008
Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapyRamin Sedaghat Herati, Van W Knox, Patricia O'Donnell, et al.Human Gene Therapy. Clinical Development|February 12, 2015
A review of gene therapy in canine and feline models of lysosomal storage disordersAllison M Bradbury, Brittney L Gurda, Margret L Casal, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 18, 2009
Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VIILachlan J Smith, John T Martin, Spencer E Szczesny, et al.Molecular Genetics and Metabolism|April 19, 2012
Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogsLachlan J Smith, John T Martin, Patricia O'Donnell, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 6, 2014
Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogsJoseph A Chiaro, Patricia O'Donnell, Eileen M Shore, et al.Thrombosis Research|November 11, 2006
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and miceLingfei Xu, Manxue Mei, Mark E Haskins, et al.The Journal of Clinical Investigation|July 26, 2008
Immune response hinders therapy for lysosomal storage diseasesKatherine P PonderPageof 10